Literature DB >> 30910458

The impact of completion thyroidectomy.

R Sawant1, K Hulse2, S Sohrabi3, J C L Yeo4, K Pal5, F W Gibb6, R Adamson7, I J Nixon8.   

Abstract

INTRODUCTION: The oncological benefit of completion thyroidectomy (CT) following thyroid lobectomy (TL) is presumed to be similar to that of upfront total thyroidectomy(TT), from a patient's perspective the risk and inconvenience of further surgery adds significantly to the impact of the overall treatment. The aim of this study is to assess the impact of CT in terms of the duration of admission and associated complications.
METHODS: A study of consecutive patients with DTC identified from prospective MDT records of South-East Scotland from 2009 to 2015. Surgical data was extracted from electronic medical record.
RESULTS: Of 361 patients diagnosed with DTC, 161 (45%) had CT. The median postoperative stay was 1 day (range 1-5days). In total 22 patients (14%)suffered complications. Four patients (3%) developed postoperative haematoma. Two (1%) had an identified permanent nerve palsy on the completion side. 13 patients (8%) remained on calcium supplementation for more than 6 months postoperatively and three patients (2%) developed wound complications.
CONCLUSIONS: Our study confirms that CT is regularly performed (45%). Recent changes in international guidelines recognize increasing number of patients as eligible for a conservative approach but recommend CT based on whether upfront TT would have been recommended if the TL pathology were known from the outset. Such an approach fails to consider the additional risk and inconvenience of CT on the overall patient experience. Due to a relatively high rate of complications, only those patients who are most likely to benefit from further surgery to facilitate adjuvant radioactive iodine should be offered additional surgery.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Completion thyroidectomy; Complications; Hypocalcaemia; Oncological benefits

Mesh:

Substances:

Year:  2019        PMID: 30910458     DOI: 10.1016/j.ejso.2019.03.018

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

Review 1.  [Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Authors:  H Dralle; F Weber; A Machens; T Brandenburg; K W Schmid; D Führer-Sakel
Journal:  Chirurgie (Heidelb)       Date:  2022-09-19

Review 2.  Hemithyroidectomy versus total thyroidectomy for well differentiated T1-2 N0 thyroid cancer: systematic review and meta-analysis.

Authors:  P M Rodriguez Schaap; M Botti; R H J Otten; K M A Dreijerink; E J M Nieveen van Dijkum; H J Bonjer; A F Engelsman; C Dickhoff
Journal:  BJS Open       Date:  2020-10-06

3.  Risk of Complications in Patients Undergoing Completion Thyroidectomy after Hemithyroidectomy for Thyroid Nodule with Indeterminate Cytology: An Italian Multicentre Retrospective Study.

Authors:  Gian Luigi Canu; Fabio Medas; Federico Cappellacci; Alessio Biagio Filippo Giordano; Angela Gurrado; Claudio Gambardella; Giovanni Docimo; Francesco Feroci; Giovanni Conzo; Mario Testini; Pietro Giorgio Calò
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

4.  Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.

Authors:  Sohail Bakkar; Khaled Al-Omar; Gianluca Donatini; Qusai Aljarrah; Theodosios S Papavramidis; Gabriele Materazzi; Paolo Miccoli
Journal:  Endocrine       Date:  2021-06-10       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.